NEUROCRINE BIOSCIENCES INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Neurocrine Biosciences Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Neurocrine Biosciences Inc Return On Assets for the quarter ending September 30, 2024 was 11.4 %, a 51.7% increase year-over-year.
  • Neurocrine Biosciences Inc annual Return On Assets for 2023 was 9.02 %, a 26.5% increase from 2022.
  • Neurocrine Biosciences Inc annual Return On Assets for 2022 was 7.13 %, a 57% increase from 2021.
  • Neurocrine Biosciences Inc annual Return On Assets for 2021 was 4.54 %, a 82.9% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 11.4 +3.88 +51.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 10.5 +3.1 +41.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 12.1 +9.25 +321% Jan 1, 2024 Mar 31, 2024
Q4 2023 9.02 +1.89 +26.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 7.5 +4.72 +170% Jul 1, 2023 Sep 30, 2023
Q2 2023 7.44 +6.85 +1157% Apr 1, 2023 Jun 30, 2023
Q1 2023 2.88 -0.6 -17.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 7.13 +2.59 +57% Oct 1, 2022 Dec 31, 2022
Q3 2022 2.78 -20.8 -88.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 0.59 -20.1 -97.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 3.49 -20.9 -85.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 4.54 -22.1 -82.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 23.6 +17 +258% Jul 1, 2021 Sep 30, 2021
Q2 2021 20.7 +5.45 +35.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 24.4 +10 +69.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 26.6 +23.4 +712% Oct 1, 2020 Dec 31, 2020
Q3 2020 6.57 +4.56 +227% Jul 1, 2020 Sep 30, 2020
Q2 2020 15.3 +13.5 +736% Apr 1, 2020 Jun 30, 2020
Q1 2020 14.4 +18.6 Jan 1, 2020 Mar 31, 2020
Q4 2019 3.28 +0.92 +38.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 2.01 +0.84 +71.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 1.83 +8.25 Apr 1, 2019 Jun 30, 2019
Q1 2019 -4.21 +9.26 +68.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 2.36 +24 Oct 1, 2018 Dec 31, 2018
Q3 2018 1.17 +36.8 Jul 1, 2018 Sep 30, 2018
Q2 2018 -6.42 +42.2 +86.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -13.5 +40.5 +75.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -21.7 +12.5 +36.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -35.6 -7.07 -24.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -48.7 -22.1 -83.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -54 -31.9 -144% Jan 1, 2017 Mar 31, 2017
Q4 2016 -34.1 -16.4 -92.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -28.5 -10.7 -60.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -26.6 -10.9 -69% Apr 1, 2016 Jun 30, 2016
Q1 2016 -22.1 -6.71 -43.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -17.7 +5.34 +23.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -17.8 +3.71 +17.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -15.7 +5.9 +27.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -15.4 +8.3 +35.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -23.1 +4.06 +15% Oct 1, 2014 Dec 31, 2014
Q3 2014 -21.5 -7.12 -49.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -21.6 -12.1 -126% Apr 1, 2014 Jun 30, 2014
Q1 2014 -23.7 -20.5 -645% Jan 1, 2014 Mar 31, 2014
Q4 2013 -27.1 -29.6 -1182% Oct 1, 2013 Dec 31, 2013
Q3 2013 -14.4 -12.7 -755% Jul 1, 2013 Sep 30, 2013
Q2 2013 -9.58 -27.5 -153% Apr 1, 2013 Jun 30, 2013
Q1 2013 -3.18 -24.8 -115% Jan 1, 2013 Mar 31, 2013
Q4 2012 2.51 Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.69 Jul 1, 2012 Sep 30, 2012
Q2 2012 17.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 21.6 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.